Table of contents

Original article

• Introduction (1 October, 2000)

  ALAN KNOX, ANDREW SZCZEKLIK, GIAMPIERO PATRIARCA
• Aspirin and other anti-inflammatory drugs (1 October, 2000)

  Sir John Vane
• Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking (1 October, 2000)

  Charles N Serhan, Clary B Clish
• A new class of lipid mediators: cytochrome P450 arachidonate metabolites (1 October, 2000)

  Mairead A Carroll, John C McGiff
• Unusual effects of aspirin on ticlopidine induced thrombolysis (1 October, 2000)

  R J Gryglewski, W Uracz, J Święs
• Epidemiology of chronic rhinosinusitis (1 October, 2000)

  P Van Cauwenberge, J B Watelet
• Perennial allergic rhinitis and keratoconjunctivitis (1 October, 2000)

  J P Rihoux
• Haemopoietic mechanisms in nasal polyposis and asthma (1 October, 2000)

  Judah A Denburg
• United airways disease: therapeutic aspects (1 October, 2000)

  Giovanni Passalacqua, Giorgio Ciprandi, Giorgio Walter Canonica
• Variant LTC₄ synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

  (1 October, 2000)

  A P Sampson, S Siddiqui, D Buchanan, P H Howarth, S T Holgate, J W Holloway, I Sayers
• Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways (1 October, 2000)

  Alan R Leff
• Lipoxins and other arachidonate derived mediators in bronchial asthma (1 October, 2000)

  C Chavis, I Vachier, P Godard, J Bousquet, P Chanez
• Clinical features and diagnosis of aspirin induced asthma (1 October, 2000)

  Andrzej Szczeklik, Ewa Niz˙ankowska
• Genetics of aspirin induced asthma (1 October, 2000)

  Marek Sanak, Andrzej Szczeklik
• Inhaled transmembrane ion transport modulators and non-steroidal anti-inflammatory drugs in asthma (1 October, 2000)

  S Bianco, M Robuschi, A Vaghi, A Fumagalli, P Sestini
• Oxidant stress in asthma (1 October, 2000)

  Ryszard Dworski
• The importance of COX-2 inhibition for aspirin induced asthma (1 October, 2000)

  Alan Bennett
• Chronic bronchial asthma from challenge to treatment: epidemiology and social impact (1 October, 2000)

  Margherita Neri, Antonio Spanevello
• New evidence of inflammation in asthma (1 October, 2000)

  Antonio M Vignola, Rosalia Gagliardo, Daniela Guerrera, Giuseppina Chiappara, Pascal Chanez, Jean Bousquet, Giovanni Bonsignore
• Allergic reactions to drugs: involvement of T cells (1 October, 2000)

  Werner J Pichler, Nikhil Yawalkar
• The aspirin disease (1 October, 2000)

  D Schiavino, E Nucera, A Milani, M Del Ninno, A Buonomo, J Sun, G Patriarca
• Aspirin induced adverse skin reactions: new pathophysiological aspects (1 October, 2000)

  Bettina Wedi, Alexander Kapp
• Hypersensitivity to pyrazolones (1 October, 2000)

  Micha Levy
• Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies (1 October, 2000)

  E Nucera, D Schiavino, A Milani, M Del Ninno, C Misuraca, A Buonomo, C D'Ambrosio, G Paludetti, G Patriarca
• Nasal polyposis, eosinophil dominated inflammation, and allergy (1 October, 2000)

  Niels Mygind, Ronald Dahl, Claus Bachert
• Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different? (1 October, 2000)

  Marek L Kowalski
• Surgical treatment of nasal polyposis in patients with aspirin intolerance (1 October, 2000)

  W Hosemann